Michelle I. Silver

1.9k total citations
46 papers, 1.2k citations indexed

About

Michelle I. Silver is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Michelle I. Silver has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 23 papers in Oncology and 11 papers in Surgery. Recurrent topics in Michelle I. Silver's work include Cervical Cancer and HPV Research (35 papers), Global Cancer Incidence and Screening (19 papers) and Colorectal Cancer Screening and Detection (8 papers). Michelle I. Silver is often cited by papers focused on Cervical Cancer and HPV Research (35 papers), Global Cancer Incidence and Screening (19 papers) and Colorectal Cancer Screening and Detection (8 papers). Michelle I. Silver collaborates with scholars based in United States, Malaysia and United Kingdom. Michelle I. Silver's co-authors include Patti E. Gravitt, Anne E. Burke, Raphael P. Viscidi, Kathryn Chang, Anne F. Rositch, Pawel Gajer, Doug Fadrosh, Rebecca M. Brotman, Jacques Ravel and Michelle Shardell and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Michelle I. Silver

40 papers receiving 1.2k citations

Peers

Countries citing papers authored by Michelle I. Silver

Since Specialization

Citations

This map shows the geographic impact of Michelle I. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle I. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle I. Silver more than expected).

Fields of papers citing papers by Michelle I. Silver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle I. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle I. Silver. The network helps show where Michelle I. Silver may publish in the future.

Co-authorship network of co-authors of Michelle I. Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle I. Silver. A scholar is included among the top collaborators of Michelle I. Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle I. Silver. Michelle I. Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Multicomponent Strategy to Increase Human Papillomavirus Vaccination Rates in Primary Care 2026 ·JAMA Network Open ·(unknown), Lei Liu, Sherry Dodd, (unknown), (unknown), (unknown), (unknown), Abigail R. Barker, Virginia McKay, Michelle I. Silver, (unknown), (unknown)	0
2	Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management Guidelines 2025 ·Journal of General Internal Medicine ·Cheryl R. Clark, Jacquelyn M. Lykken, (unknown), (unknown), Sarah Feldman, Chul Ahn, (unknown), Sarah C. Kobrin, Michelle I. Silver, Steven J. Atlas, Jessica Chubak, Jasmin A. Tiro	0
3	HPV Vaccine Uptake and its Predictors among Adolescent Girls and Young Women Living with HIV-in Central Uganda 2025 ·AIDS and Behavior ·(unknown), Samuel Kizito, Jean Hunleth, Michelle I. Silver, Nixon Niyonzima, Fred M. Ssewamala	0
4	Preliminary Impact of Public Health Messaging on HPV Vaccine Uptake Among Adolescent Girls and Young Women Living with HIV in Central Uganda 2025 ·AIDS and Behavior ·(unknown), Samuel Kizito, (unknown), (unknown), Jean Hunleth, Michelle I. Silver, Nixon Niyonzima, Proscovia Nabunya, Fred M. Ssewamala	0
5	Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results 2024 ·Journal of General Internal Medicine ·(unknown), (unknown), Sarah C. Kobrin, Jasmin A. Tiro, Claudia L. Werner, Jacquelyn M. Lykken, Jessica Chubak, Steven J. Atlas, Robin T. Higashi, Simon J. Craddock Lee, Jennifer S. Haas, Celette Sugg Skinner, Michelle I. Silver, Sarah Feldman	1
6	Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings 2024 ·Cancer Epidemiology Biomarkers & Prevention ·David Cheng, (unknown), Jacquelyn M. Lykken, Claudia L. Werner, Sarah Feldman, Michelle I. Silver, Steven J. Atlas, Jasmin A. Tiro, Jennifer S. Haas, Aruna Kamineni	0
7	The association of caregiver attitudes, information sources, and trust with HPV vaccine initiation among adolescents 2024 ·Human Vaccines & Immunotherapeutics ·(unknown), (unknown), (unknown), Alan R. Barnette, Heather M. Brandt, Lisa M. Klesges, Vetta L. Sanders Thompson, Michelle I. Silver	5
8	Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study 2023 ·PLoS ONE ·(unknown), (unknown), (unknown), Ana A. Baumann, Gershom Chongwe, (unknown), Michelle I. Silver, Jean Hunleth	3
9	Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings 2023 ·American Journal of Preventive Medicine ·Jennifer C. Spencer, Jane J. Kim, Jasmin A. Tiro, Sarah Feldman, Sarah C. Kobrin, Celette Sugg Skinner, Lei Wang, Anne Marie McCarthy, Steven J. Atlas, Sandi L. Pruitt, Michelle I. Silver, Jennifer S. Haas	42
10	Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systems 2022 ·JNCI Cancer Spectrum ·Gina Kruse, Jacquelyn M. Lykken, (unknown), Jennifer S. Haas, Robin T. Higashi, Steven J. Atlas, Anne Marie McCarthy, Jasmin A. Tiro, Michelle I. Silver, Celette Sugg Skinner, Aruna Kamineni	4
11	Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Jessica Chubak, Andrea N. Burnett‐Hartman, William E. Barlow, Douglas A. Corley, Jennifer M. Croswell, Christine Neslund‐Dudas, Anil Vachani, Michelle I. Silver, Jasmin A. Tiro, Aruna Kamineni	6
12	Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach 2021 ·Preventive Medicine ·Patti E. Gravitt, Michelle I. Silver, Heather M. Hussey, Silvina Arrossi, Megan J. Huchko, José Jerónimo, Sharon Kapambwe, Somesh Kumar, (unknown), (unknown), Valerie A. Paz‐Soldán, Yin Ling Woo	35
13	Exacerbating disparities?: Cervical cancer screening and HPV vaccination 2019 ·Preventive Medicine ·Michelle I. Silver, Sarah C. Kobrin	21
14	Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years 2018 ·Cancer Prevention Research ·Michelle I. Silver, Julia C. Gage, Mark Schiffman, Barbara Fetterman, Nancy Poitras, Thomas Lorey, Li C. Cheung, Hormuzd A. Katki, (unknown), Walter Kinney, Philip E. Castle	31
15	Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression 2018 ·Obstetrics and Gynecology ·Michelle I. Silver, (unknown), Charles K. Cooper, Julia C. Gage, Michael A. Gold, Michelle J. Khan, L. Stewart Massad, Valentin Parvu, Rebecca B. Perkins, Mark Schiffman, Katie Smith, Nicolas Wentzensen	25
16	Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30–65 years 2017 ·Cancer Causes & Control ·Michelle I. Silver, Anne F. Rositch, (unknown), Patti E. Gravitt	20
17	Trends in cervical cancer incidence in younger US women from 2000 to 2013 2016 ·Gynecologic Oncology ·Daniel C. Beachler, Joseph E. Tota, Michelle I. Silver, Aimée R. Kreimer, Allan Hildesheim, Nicolas Wentzensen, Mark Schiffman, Meredith S. Shiels	13
18	Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy 2013 ·Menopause The Journal of The North American Menopause Society ·Rebecca M. Brotman, Michelle Shardell, Pawel Gajer, Doug Fadrosh, Kathryn Chang, Michelle I. Silver, Raphael P. Viscidi, Anne E. Burke, Jacques Ravel, Patti E. Gravitt	298
19	The Correlation Between Human Papillomavirus Positivity and Abnormal Cervical Cytology Result Differs by Age Among Perimenopausal Women 2012 ·Journal of Lower Genital Tract Disease ·Anne F. Rositch, Michelle I. Silver, Anne E. Burke, Raphael P. Viscidi, Kathryn Chang, (unknown), Wen Shen, Patti E. Gravitt	23
20	Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) Positivity in Cervical Cancer Screening of Women in a Peri-Urban Area in Andhra Pradesh, India 2010 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Michelle I. Silver, (unknown), (unknown), (unknown), (unknown), (unknown), Brigitte M. Ronnett, K. Vijayaraghavan, Gayatri Ramakrishna, (unknown), (unknown), Keerti V. Shah, Patti E. Gravitt	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact